Department of Computer Engineering, Faculty of Engineering, Ankara University, 06830 Ankara, Turkey.
Department of Analytical Chemistry, Faculty of Gülhane Pharmacy, University of Health Sciences, 06018 Ankara, Turkey.
Sensors (Basel). 2023 Mar 13;23(6):3080. doi: 10.3390/s23063080.
Data from omics studies have been used for prediction and classification of various diseases in biomedical and bioinformatics research. In recent years, Machine Learning (ML) algorithms have been used in many different fields related to healthcare systems, especially for disease prediction and classification tasks. Integration of molecular omics data with ML algorithms has offered a great opportunity to evaluate clinical data. RNA sequence (RNA-seq) analysis has been emerged as the gold standard for transcriptomics analysis. Currently, it is being used widely in clinical research. In our present work, RNA-seq data of extracellular vesicles (EV) from healthy and colon cancer patients are analyzed. Our aim is to develop models for prediction and classification of colon cancer stages. Five different canonical ML and Deep Learning (DL) classifiers are used to predict colon cancer of an individual with processed RNA-seq data. The classes of data are formed on the basis of both colon cancer stages and cancer presence (healthy or cancer). The canonical ML classifiers, which are k-Nearest Neighbor (kNN), Logistic Model Tree (LMT), Random Tree (RT), Random Committee (RC), and Random Forest (RF), are tested with both forms of the data. In addition, to compare the performance with canonical ML models, One-Dimensional Convolutional Neural Network (1-D CNN), Long Short-Term Memory (LSTM), and Bidirectional LSTM (BiLSTM) DL models are utilized. Hyper-parameter optimizations of DL models are constructed by using genetic meta-heuristic optimization algorithm (GA). The best accuracy in cancer prediction is obtained with RC, LMT, and RF canonical ML algorithms as 97.33%. However, RT and kNN show 95.33% performance. The best accuracy in cancer stage classification is achieved with RF as 97.33%. This result is followed by LMT, RC, kNN, and RT with 96.33%, 96%, 94.66%, and 94%, respectively. According to the results of the experiments with DL algorithms, the best accuracy in cancer prediction is obtained with 1-D CNN as 97.67%. BiLSTM and LSTM show 94.33% and 93.67% performance, respectively. In classification of the cancer stages, the best accuracy is achieved with BiLSTM as 98%. 1-D CNN and LSTM show 97% and 94.33% performance, respectively. The results reveal that both canonical ML and DL models may outperform each other for different numbers of features.
来自组学研究的数据已被用于生物医学和生物信息学研究中各种疾病的预测和分类。近年来,机器学习(ML)算法已被用于医疗保健系统的许多不同领域,尤其是用于疾病预测和分类任务。将分子组学数据与 ML 算法集成提供了评估临床数据的绝佳机会。RNA 序列(RNA-seq)分析已成为转录组学分析的金标准。目前,它在临床研究中得到了广泛应用。在我们目前的工作中,分析了来自健康和结肠癌患者的细胞外囊泡(EV)的 RNA-seq 数据。我们的目标是开发用于预测和分类结肠癌阶段的模型。使用五种不同的经典机器学习和深度学习(DL)分类器来预测个体的结肠癌,使用经过处理的 RNA-seq 数据。数据类别是基于结肠癌阶段和癌症存在(健康或癌症)形成的。经典的机器学习分类器,包括 k-最近邻(kNN)、Logistic 模型树(LMT)、随机树(RT)、随机委员会(RC)和随机森林(RF),都使用这两种数据形式进行了测试。此外,为了与经典 ML 模型进行比较,使用一维卷积神经网络(1-D CNN)、长短期记忆(LSTM)和双向 LSTM(BiLSTM)DL 模型进行了测试。通过遗传元启发式优化算法(GA)对 DL 模型的超参数优化进行构建。RC、LMT 和 RF 经典 ML 算法在癌症预测中的最佳准确率为 97.33%。然而,RT 和 kNN 的性能分别为 95.33%和 94.66%。RF 在癌症阶段分类中的最佳准确率为 97.33%。其次是 LMT、RC、kNN 和 RT,准确率分别为 96.33%、96%、94.66%和 94%。根据与 DL 算法的实验结果,1-D CNN 在癌症预测中的最佳准确率为 97.67%。BiLSTM 和 LSTM 的性能分别为 94.33%和 93.67%。在癌症阶段的分类中,BiLSTM 的最佳准确率为 98%。1-D CNN 和 LSTM 的准确率分别为 97%和 94.33%。结果表明,对于不同数量的特征,经典 ML 和 DL 模型可能会相互超越。